Search results for "Press"

showing 10 items of 15058 documents

Visual processing in patients with age-related macular degeneration performing a face detection test

2017

Purpose: People with age-related macular degeneration (AMD) have difficulties in familiar face recognition and facial expression discrimination. Our aim was to evaluate the visual processing of faces in AMD patients and whether this would be improved by anti-vascular endothelial growth factor therapy. This was a prospective interventional cohort study. Patients: Twelve patients with monocular wet AMD and 6 control subjects were recruited. Face detection processes were studied using cortical event-related potentials (ERPs). Patients received 3 bevacizumab intravitreal injections to the single affected eye. At baseline and 4–6 weeks after the last injection, clinical presentation and ERPs of …

medicine.medical_specialtyVisual acuityBevacizumabgenetic structuresfacial expressionsElectroencephalographybevacizumabfacial recognitionVisual processing03 medical and health sciences0302 clinical medicineOphthalmologymedicineilmeetEEGage-related eye diseasesFace detectionta315tunnistaminenOriginal ResearchFacial expressionMonocularmedicine.diagnostic_testbusiness.industryvisuaalisuuseye diseasesta3141Clinical OphthalmologyMacular degenerationRE1-994medicine.diseaseeye diseasesOphthalmologyvisualityN170silmätaudit030221 ophthalmology & optometrysense organsmedicine.symptomrecognitionbusiness030217 neurology & neurosurgerykasvontunnistus (tietotekniikka)medicine.drugface recognitionClinical Ophthalmology
researchProduct

ATD perimetry in glaucoma and ocular hypertensive patients. A preliminar study

2007

Purpose: The new ATD perimetry assesses contrast sentivity thresholds for the three afferent sensory pathways of the visual system. Our aim is to compare contrast sensitivity to stimuli with different spatio-temporal frequencies in glaucomatous (G) and ocular hypertensive (OHT) subjects. Methods: Twenty three G and OHT subjects were selected from the ophthalmic clinic, all subjects signed an informed consent. Inclusion criteria were diagnosis of G or OHT, normal Farnsworth-Munsell color test, ametropia less than 6 D, visual acuity over 20/30, absence of previous ocular surgery and experience in perimetry. Twenty locations and the fovea were evaluated in a 60o x 40o fovea-centered field. Eig…

medicine.medical_specialtyVisual acuitybusiness.industryOcular surgeryColor testGlaucomamedicine.diseaseOphthalmologyAfferentOphthalmologymedicineStatistical analysisAnalysis of variancemedicine.symptomHigh intraocular pressurebusinessActa Ophthalmologica Scandinavica
researchProduct

The relevance of depressive symptoms for the outcome of patients receiving vitamin K antagonists: results from the thrombEVAL cohort study.

2020

Abstract Aims Although depressive symptoms are highly prevalent in patients receiving oral anticoagulation (OAC), the relevance of depression for the outcome of anticoagulated individuals is unknown. Methods and results We analysed data from the multicentre cohort study thrombEVAL (NCT01809015) investigating the efficacy of OAC with vitamin K antagonists. There was an independent study monitoring, and an independent review panel assessed the endpoints. Out of n = 1558 participants, information about depressive symptoms, as measured by the two-item screener of the patient health questionnaire (PHQ-2), was available in n = 1405 individuals. The mean follow-up period was 28.04 months, with a s…

medicine.medical_specialtyVitamin KProportional hazards modelbusiness.industryDepressionHazard ratioAnticoagulantsVitamin kConfidence intervalPatient Health QuestionnaireCohort StudiesInternal medicineThromboembolismmedicineHumansPharmacology (medical)Cardiology and Cardiovascular MedicineAdverse effectbusinessDepression (differential diagnoses)Cohort studyEuropean heart journal. Cardiovascular pharmacotherapy
researchProduct

Both poor cardiorespiratory and weak muscle fitness are related to a high concentration of oxidized low-density lipoprotein lipids

2011

Good physical fitness is associated with favorable serum lipids. Oxidized low-density lipoprotein (ox-LDL) could be even more atherogenic than serum lipids. We studied the association of ox-LDL and serum lipids with physical fitness. Healthy young (mean age 25 years) men (n=846) underwent maximal oxygen uptake (VO(2max)) and muscle fitness index (MFI) tests and completed a leisure-time physical activity (LTPA) questionnaire. Age (ANCOVA1), age+waist circumference+systolic blood pressure+fasting blood glucose+smoking (ANCOVA3) were used as covariates. The groups with the lowest VO(2max), MFI and LTPA had 23%, 16% and 8% higher concentrations of ox-LDL than the groups with the highest VO(2max…

medicine.medical_specialtyWaistbusiness.industryPhysical fitnessOxidized low density lipoproteinBlood lipidsVO2 maxPhysical Therapy Sports Therapy and RehabilitationCardiorespiratory fitnessEndocrinologyBlood pressureInternal medicinemedicinelipids (amino acids peptides and proteins)Orthopedics and Sports MedicinebusinessLipoproteinScandinavian Journal of Medicine & Science in Sports
researchProduct

Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diab…

2021

This study investigates the effects of dapagliflozin on the visceral adiposity index (VAI), lipid accumulation product (LAP), product of triglycerides and glucose (TyG) and triglycerides to HDL-cholesterol ratio (TG/HDL-C) in patients with type 2 diabetes mellitus (T2D). In this real-life study, dapaglifozin was added to metformin alone (group 1, no. 42) or insulin plus metformin (group 2, no. 58) in 100 T2D patients. In group 1, after 6 months of dapaglifozin addition, a significant decrease in BMI (p < 0.001), waist circumference (WC) (p < 0.001), systolic blood pressure (SBP) (p = 0.009), diastolic blood pressure (DBP) (p = 0.012), mean fasting blood glucose (FBG), post-breakfast glucose…

medicine.medical_specialtyWaistendocrine system diseasesbusiness.industryEndocrinology Diabetes and MetabolismInsulinmedicine.medical_treatmentnutritional and metabolic diseasesCorrectionmedicine.diseaseGastroenterologyMetforminnot applicablechemistry.chemical_compoundInsulin resistanceBlood pressurechemistryDiabetes mellitusInternal medicineInternal MedicinemedicineDapagliflozinbusinessLipid Accumulation Productmedicine.drugDiabetes Therapy
researchProduct

Noninvasive Positive Pressure Ventilation in Amyotrophic Lateral Sclerosis

2010

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of unknown origin that affects approximately 1.5 individuals per 100,000 every year; usually, these individuals are between 55 and 75 years of age [1]. ALS causes progressive weakness of voluntary muscle groups, including respiratory ones, and respiratory failure or pneumonia related to respiratory muscle weakness is the most frequent cause of death.

medicine.medical_specialtyWeaknessbusiness.industryDiseasemedicine.diseasePneumoniaRespiratory failureInternal medicinemedicineCardiologyRespiratory systemAmyotrophic lateral sclerosismedicine.symptombusinessPositive pressure ventilationCause of death
researchProduct

Hypertension in Children and Adolescents

2019

During the last few decades, hypertension in children and adolescents has gained ground in cardiovascular medicine, thanks to the progress made in several areas of pathophysiological and clinical research. The prevalence in school-aged children appears to be increasing, perhaps as a result of the increased prevalence of obesity in the last years. Despite evidence of an increasing prevalence of hypertension in the young, the consequences of early onset hypertension are poorly established and often overlooked. In children hypertension can be caused by multiple conditions, and therefore it is warranted to consider a wide range of differential diagnoses and to search for definable causes of hyp…

medicine.medical_specialtyWindow of opportunityLife spanbusiness.industryDisease030204 cardiovascular system & hematologymedicine.diseaseObesityOrgan damage03 medical and health sciences0302 clinical medicineClinical researchCentral blood pressureMedicine030212 general & internal medicinebusinessIntensive care medicineEarly onset
researchProduct

Des lésions cutanées diffuses

2015

International audience

medicine.medical_specialty[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyNorwegian scabies030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineElderlyInternal MedicinemedicinePersonne âgéeImmunodepressionComputingMilieux_MISCELLANEOUS0303 health sciencesmedicine.diagnostic_test030306 microbiologybusiness.industry[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyGastroenterologymedicine.diseaseDermatologyGale norvégienneNorwegian scabiesPositron emission tomographySarcoidosisbusinessPanniculitis[ SDV.MHEP.DERM ] Life Sciences [q-bio]/Human health and pathology/Dermatology[SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology
researchProduct

Transferrin gene expression in the mammary gland of the rat. The enhancing effect of 17 beta-oestradiol on the level of RNA is tissue-specific.

1993

We have investigated the physiological factors which regulate transferrin gene expression in the mammary gland of the rat. Our studies by dot blot analysis have demonstrated that multiple doses of 17β-oestradiol (OE2; 0·5 mg/kg per day for 3 days) elicit a specific 3·5-fold increase in the transferrin mRNA levels in the mammary glands of virgin rats. The hormonal action of OE2 in mammary tissue was specific for the transferrin gene, as judged by hybridization with β-actin cDNA. The accmulation of transferrin mRNA induced by OE2 treatment was similar to the developmentally regulated expression of the gene observed during the reproductive cycle. The steady-state level of mammary transferrin m…

medicine.medical_specialty[SDV]Life Sciences [q-bio]Mammary glandUterusBiologyEndocrinologyMammary Glands AnimalLactationInternal medicineGene expressionmedicineAnimalsRNA MessengerRats WistarMolecular BiologyGeneComputingMilieux_MISCELLANEOUSchemistry.chemical_classificationMessenger RNAEstradiolUterusTransferrinMilk ProteinsRats[SDV] Life Sciences [q-bio]Endocrinologymedicine.anatomical_structurechemistryGene Expression RegulationLiverTransferrinOrgan SpecificityOESTRADIOL A-BETARATFemaleHormoneJournal of molecular endocrinology
researchProduct

Effects of High Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) on Delay Discounting in Major Depressive Disorder: An Open-Label Unc…

2019

Background: Delay discounting (DD) refers to the decrease of a present subjective value of a future reward as the delay of its delivery increases. Major depressive disorder (MDD), besides core emotional and physical symptoms, involves difficulties in reward processing. Depressed patients often display greater temporal discounting rates than healthy subjects. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique applied in several countries to adult patients with treatment resistant depression. Studies suggest that this technique can be used to modulate DD, but no trial has assessed its effects on depressed patients. Methods: In this open-label unc…

medicine.medical_specialty[SDV]Life Sciences [q-bio]medicine.medical_treatmentimpulsivityAudiologyImpulsivitybehavioral disciplines and activitiesArticlelcsh:RC321-57103 medical and health sciences0302 clinical medicinemental disordersmedicineTemporal discountinglcsh:Neurosciences. Biological psychiatry. Neuropsychiatrydelay discountingmajor depressive disorderbusiness.industryGeneral Neurosciencerepetitive transcranial magnetic stimulationhigh frequency repetitive transcranial magnetic stimulationCognitionmedicine.disease030227 psychiatry3. Good healthDorsolateral prefrontal cortexTranscranial magnetic stimulationmedicine.anatomical_structure[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthBrain stimulationMajor depressive disordermedicine.symptombusinessTreatment-resistant depression030217 neurology & neurosurgeryBrain Sciences
researchProduct